Prognostic value of the combination of microsatellite instability and <em>BRAF</em> mutation in colorectal cancer

Yingchi Yang(Capital Medical University), Zhongtao Zhang(Capital Medical University), Zhigang Bai(Yale Cancer Center), Jin Wang(Shanghai Public Health Clinical Center), Dong Wang(Capital Medical University), Lan Jin(Capital Medical University), Guocong Wu(Capital Medical University), Hongwei Yao(Capital Medical University)
Cancer Management and Research
September 1, 2018
10.2147/cmar.s169649
Cited by 28

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial
|The Lancet Oncology|2021|184
Exosomal miR-146a-5p and miR-155-5p promote CXCL12/CXCR7-induced metastasis of colorectal cancer by crosstalk with cancer-associated fibroblasts
|Cell Death and Disease|2022|155
A Multicenter Study on Etiology of Acute Pancreatitis in Beijing During 5 Years
|Pancreas|2014|147
CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade
|Cancer Discovery|2020|143